{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:39:40Z","timestamp":1792395580653,"version":"4.4.0"},"reference-count":40,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["RAAIDD"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>For a long time, third-generation cephalosporins (TGCs) have\nbeen the first-line therapy for spontaneous bacterial peritonitis (SBP) in cirrhotic patients.\nHowever, their efficacy has been questioned in recent years. This study aimed to assess the\nclinical characteristics, bacterial spectrum, initial treatment response, and in-hospital mortality\nrate among a cohort of Egyptian cirrhotic patients diagnosed with SBP and treated\nwith TGCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A total of 107 cirrhotic patients with SBP were included in this prospective cohort\nstudy. All included patients received TGCs as first-line therapy. Baseline characteristics (both\nclinical and laboratory), initial treatment response, and the rate of in-hospital mortality were\ndocumented and compared between treatment responders and non-responders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Antibiotic response rate was as follows: 20 patients (18.7%) showed a primary\nresponse to TGCs treatment, while 63 (58.9%) showed a response only after switching to\nmore appropriate antibiotics elevatingthe final response to 77.6%. History of repeated attacks\nof SBP, presence of refractory ascites and elevated alkalinephosphatase levels were\nsignificantly more frequent among patients who did not achieve primary response(P=\n0.002, 0.048, and 0.029, respectively), with no significant difference concerning the rate of\nin-hospital mortality among the studied groups (P= 0.276). Regarding ascitic fluid culture,\nEscherichia coli was the most commonly isolated organism (23%), while no bacterial\ngrowth was found among 49 (56.3%) of the non-responders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>Increased resistance to TGCs necessitates evaluation of patients' history and\nclinical assessment to re-escalate antibiotics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>A history of recurrent SBP or the presence of refractory ascites should preclude\nthe use of TGC as first-line therapy in cirrhotic patients with SBP.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0127724344429679260220073151","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:58:29Z","timestamp":1774864709000},"page":"306-317","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Third-Generation Cephalosporins for Spontaneous Bacterial Peritonitis: Clinical Characteristics for Treatment Response in Cirrhotic Patients: A Cohort Study"],"prefix":"10.2174","volume":"21","author":[{"given":"Fathia Elsayed","family":"Assal","sequence":"first","affiliation":[{"name":"Department of Tropical medicine and infectious diseases, Tanta University, Tanta, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Elsayed","family":"Elhendawy","sequence":"additional","affiliation":[{"name":"Department of Tropical medicine and infectious diseases, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas Mohamed","family":"Abo Eta","sequence":"additional","affiliation":[{"name":"Department of Tropical medicine and infectious diseases, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesam Hatem","family":"Amer","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Abd","family":"Elhai","sequence":"additional","affiliation":[{"name":"Department of Clinical pathology, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferial Salah","family":"Eldein Elkalla","sequence":"additional","affiliation":[{"name":"Department of Tropical medicine and infectious diseases, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Elsayed","family":"Enar","sequence":"additional","affiliation":[{"name":"Ministry of Health, Cairo, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherif","family":"Abdelbaky","sequence":"additional","affiliation":[{"name":"Department of Tropical medicine and infectious diseases, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehad Ibrahim","family":"Hawash","sequence":"additional","affiliation":[{"name":"Department of Tropical medicine and infectious diseases, Tanta University, Tanta, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.4254\/wjh.v9.i30.1166","volume":"9","author":"Fiore M.","year":"2017","unstructured":"Fiore M.; Maraolo A.E.; Gentile I.; Current concepts and future strategies in the antimicrobial therapy of emerging Gram-positive spontaneous bacterial peritonitis. World J Hepatol  2017,9(30),1166-75","journal-title":"World J Hepatol"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","volume":"69","author":"Angeli P.","year":"2018","unstructured":"Angeli P.; Bernardi M.; Villanueva C.; EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol  2018,69(2),406-60","journal-title":"J Hepatol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4254\/wjh.v8.i6.307","volume":"8","author":"Bunchorntavakul C.","year":"2016","unstructured":"Bunchorntavakul C.; Chamroonkul N.; Chavalitdham-rong D.; Bacterial infections in cirrhosis: A critical review and practical guidance. World J Hepatol  2016,8(6),307-21","journal-title":"World J Hepatol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"419","DOI":"10.11622\/smedj.2019085","volume":"61","author":"Wong Y.J.","year":"2020","unstructured":"Wong Y.J.; Kalki R.C.; Lin K.W.; Short- and long-term predictors of spontaneous bacterial peritonitis in Singapore. Singapore Med J  2020,61(8),419-25","journal-title":"Singapore Med J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1097\/MEG.0000000000000700","volume":"28","author":"Oliveira A.M.","year":"2016","unstructured":"Oliveira A.M.; Branco J.C.; Barosa R.; Clinical and microbiological characteristics associated with mortality in spontaneous bacterial peritonitis: A multicenter cohort study. Eur J Gastroenterol Hepatol  2016,28(10),1216-22","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000518585","volume":"29","author":"Pimentel R.","year":"2022","unstructured":"Pimentel R.; Leit\u00e3o J.; Greg\u00f3rio C.; Santos L.; Carvalho A.; Figueiredo P.; Spontaneous bacterial peritonitis in cirrhotic patients: A shift in the microbial pattern? a retrospective analysis. GE Port J Gastroenterol  2022,29(4),256-66","journal-title":"GE Port J Gastroenterol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2010.05.004","volume":"53","year":"2010","unstructured":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol  2010,53(3),397-417","journal-title":"J Hepatol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/eci.12701","volume":"47","author":"Lutz P.","year":"2017","unstructured":"Lutz P.; Nischalke H.D.; Kr\u00e4mer B.; Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis. Eur J Clin Invest  2017,47(1),44-52","journal-title":"Eur J Clin Invest"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1177\/2050640617744456","volume":"6","author":"Oey R.C.","year":"2018","unstructured":"Oey R.C.; de Man R.A.; Erler N.S.; Verbon A.; van Buuren H.R.; Microbiology and antibiotic suscept-ibility patterns in spontaneous bacterial peritonitis: A study of two Dutch cohorts at a 10-year interval. United European Gastroenterol J  2018,6(4),614-21","journal-title":"United European Gastroenterol J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1590\/s0004-2803.201800000-08","volume":"55","author":"Almeida P.R.L.","year":"2018","unstructured":"Almeida P.R.L.; Le\u00e3o G.S.; Gon\u00e7alves C.D.G.; Picon R.V.; Tovo C.V.; Impact of microbiological changes on spontaneous bacterial peritonitis in three different periods over 17 years. Arq Gastroenterol  2018,55(1),23-7","journal-title":"Arq Gastroenterol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jhep.2011.11.010","volume":"56","author":"Ariza X.","year":"2012","unstructured":"Ariza X.; Castellote J.; Lora-Tamayo J.; Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis. J Hepatol  2012,56(4),825-32","journal-title":"J Hepatol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/hep.25532","volume":"55","author":"Fern\u00e1ndez J.","year":"2012","unstructured":"Fern\u00e1ndez J.; Acevedo J.; Castro M.; Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study. Hepatology  2012,55(5),1551-61","journal-title":"Hepatology"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"13198","DOI":"10.1111\/eci.13198","volume":"50","author":"Li H.","year":"2020","unstructured":"Li H.; Wieser A.; Zhang J.; Patients with cirrhosis and SBP: Increase in multidrug-resistant organisms and complications. Eur J Clin Invest  2020,50(2),13198","journal-title":"Eur J Clin Invest"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/j.1478-3231.2004.0991.x","volume":"24","author":"Moreau R.","year":"2004","unstructured":"Moreau R.; Del\u00e8gue P.; Pessione F.; Clinical characteristics and outcome of patients with cirrhosis and refractory ascites. Liver Int  2004,24(5),457-64","journal-title":"Liver Int"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3350\/cmh.2022.0104","volume":"29","author":"Wong F.","year":"2023","unstructured":"Wong F.; Management of refractory ascites. Clin Mol Hepatol  2023,29(1),16-32","journal-title":"Clin Mol Hepatol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/hep.31884","volume":"74","author":"Biggins S.W.","year":"2021","unstructured":"Biggins S.W.; Angeli P.; Garcia-Tsao G.; Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 practice guidance by the american association for the study of liver diseases. Hepatology  2021,74(2),1014-48","journal-title":"Hepatology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.18576\/ab\/010102","volume":"1","author":"Elsherif A.A.","year":"2016","unstructured":"Elsherif A.A.; Eldahshan M.A.; Hussein M.S.; Mohamed A.M.; Asymptomatic spontaneous bacterial peritonitis in adult Egyptian patients with decompensated liver cirrhosis: A prospective cohort study. Inter J Adv Biomed  2016,1(1),5-9","journal-title":"Inter J Adv Biomed"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/917856","volume":"2014","author":"Sheikhbahaei S.","year":"2014","unstructured":"Sheikhbahaei S.; Abdollahi A.; Hafezi-Nejad N.; Zare E.; Patterns of antimicrobial resistance in the causative organisms of spontaneous bacterial peritonitis: A single centre, six-year experience of 1981 samples. Int J Hepatol  2014,2014,1-6","journal-title":"Int J Hepatol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1111\/jgh.13266","volume":"31","author":"Friedrich K.","year":"2016","unstructured":"Friedrich K.; N\u00fcssle S.; Rehlen T.; Stremmel W.; Mischnik A.; Eisenbach C.; Microbiology and resistance in first episodes of spontaneous bacterial peritonitis: Implications for management and prognosis. J Gastroenterol Hepatol  2016,31(6),1191-5","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/6963910","volume":"2019","author":"Oliveira J.D.C.","year":"2019","unstructured":"Oliveira J.D.C.; Carrera E.; Petry R.C.; High prevalence of multidrug resistant bacteria in cirrhotic patients with spontaneous bacterial peritonitis: Is it time to change the standard antimicrobial approach? Can J Gastroenterol Hepatol  2019,2019,1-6","journal-title":"Can J Gastroenterol Hepatol"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3748\/wjg.v19.i8.1271","volume":"19","author":"Badawy A.A.","year":"2013","unstructured":"Badawy A.A.; Zaher T.I.; Sharaf S.M.; Emara M.H.; Shaheen N.E.; Aly T.F.; Effect of alternative antibiotics in treatment of cefotaxime resistant spontaneous bacterial peritonitis. World J Gastroenterol  2013,19(8),1271-7","journal-title":"World J Gastroenterol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"30164","DOI":"10.1097\/MD.0000000000030164","volume":"101","author":"Zhu L.C.","year":"2022","unstructured":"Zhu L.C.; Wu W.; Zou B.; Efficacy predictors of third-generation cephalosporins in treating spontaneous bacterial peritonitis. Medicine  2022,101(40),30164","journal-title":"Medicine"},{"key":"ref=23","doi-asserted-by":"publisher","DOI":"10.21608\/mid.2024.295371.1979","author":"Elabd N.S.","year":"2024","unstructured":"Elabd N.S.; Mohammed H.I.; El-Gazzarah A.R.; Frequency of spontaneous bacterial peritonitis among cirrhotic ascitic patients and predictors for its outcome in Menoufia University Hospitals. Microb Infect Diseases  2024","journal-title":"Microb Infect Diseases"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.15406\/jbmoa.2018.06.00196","volume":"6","author":"Gharabawy S.E.","year":"2018","unstructured":"Gharabawy S.E.; Mashad N.E.; Sheta T.F.; Prevalence and microbiological features of spontaneous bacterial peritonitis in hospitalized ascitic patients: Single center study. J Bacteriol Mycol Open Access  2018,6(2),160-3","journal-title":"J Bacteriol Mycol Open Access"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.21608\/bmfj.2022.97727.1490","author":"Abd-Elsalam F.","year":"2022","unstructured":"Abd-Elsalam F.; Zeinelabedin M.; Abdelrahman S.; Gabal H.; Bacteriological profile and antimicrobial resistance in ascitic fluid of patients with community acquired and nosocomial spontaneous bacterial peritonitis. Benha Med J  2022","journal-title":"Benha Med J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/apt.13172","volume":"41","author":"Dever J.B.","year":"2015","unstructured":"Dever J.B.; Sheikh M.Y.; Review article: Spontaneous bacterial peritonitis \u2013 bacteriology, diagnosis, treatment, risk factors and prevention. Aliment Pharmacol Ther  2015,41(11),1116-31","journal-title":"Aliment Pharmacol Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12879-019-4102-4","volume":"19","author":"Ding X.","year":"2019","unstructured":"Ding X.; Yu Y.; Chen M.; Wang C.; Kang Y.; Lou J.; Causative agents and outcome of spontaneous bacterial peritonitis in cirrhotic patients: Community-acquired versus nosocomial infections. BMC Infect Dis  2019,19(1),463","journal-title":"BMC Infect Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.aohep.2020.04.010","volume":"19","author":"Mattos A.A.","year":"2020","unstructured":"Mattos A.A.; Wiltgen D.; Jotz R.F.; Dornelles C.M.R.; Fernandes M.V.; Mattos \u00c2.Z.; Spontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis. Ann Hepatol  2020,19(5),451-7","journal-title":"Ann Hepatol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.31729\/jnma.8124","volume":"61","author":"Mahato T.","year":"2023","unstructured":"Mahato T.; Sharma Y.; Thapa S.; Spontaneous bacterial peritonitis among chronic liver disease patients with ascites admitted to the department of medicine of a tertiary care centre: A descriptive cross-sectional study. JNMA J Nepal Med Assoc  2023,61(260),300-4","journal-title":"JNMA J Nepal Med Assoc"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/HMER.S369966","volume":"14","author":"Nguyen L.C.","year":"2022","unstructured":"Nguyen L.C.; Lo T.T.B.; La H.D.; Doan H.T.N.; Le N.T.; Clinical, laboratory and bacterial profile of spontan-eous bacterial peritonitis in Vietnamese patients with liver cirrhosis. Hepat Med  2022,14,101-9","journal-title":"Hepat Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1053\/j.gastro.2014.08.029","volume":"147","author":"Lammers W.J.","year":"2014","unstructured":"Lammers W.J.; van Buuren H.R.; Hirschfield G.M.; Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study. Gastroenterology  2014,147(6),1338-1349.e5","journal-title":"Gastroenterology"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0168-8278(00)00039-8","volume":"34","author":"Wu S.S.","year":"2001","unstructured":"Wu S.S.; Lin O.S.; Chen Y.Y.; Hwang K.L.; Soon M.S.; Keeffe E.B.; Ascitic fluid carcinoembryonic antigen and alkaline phosphatase levels for the differentiation of primary from secondary bacterial peritonitis with intestinal perforation. J Hepatol  2001,34(2),215-221","journal-title":"J Hepatol"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1097\/MEG.0000000000000724","volume":"28","author":"Elfert A.","year":"2016","unstructured":"Elfert A.; Abo Ali L.; Soliman S.; Ibrahim S.; Abd-Elsalam S.; Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol  2016,28(12),1450-4","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"5833","DOI":"10.1002\/jmv.27122","volume":"93","author":"Abd-Elsalam S.","year":"2021","unstructured":"Abd-Elsalam S.; Noor R.A.; Badawi R.; Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study. J Med Virol  2021,93(10),5833-8","journal-title":"J Med Virol"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/liv.14775","volume":"41","author":"Emara M.H.","year":"2021","unstructured":"Emara M.H.; Soliman H.H.; Elnadry M.; Ramadan fasting and liver diseases: A review with practice advices and recommendations. Liver Int  2021,41(3),436-448","journal-title":"Liver Int"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1097\/MEG.0000000000000688","volume":"28","author":"Sheta E.","year":"2016","unstructured":"Sheta E.; El-Kalla F.; El-Gharib M.; Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: A randomized-controlled study. Eur J Gastroenterol Hepatol  2016,28(10),1198-203","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/9616234","volume":"2018","author":"Ahmed O.A.","year":"2018","unstructured":"Ahmed O.A.; Safwat E.; Khalifa M.O.; Sofosbuvir plus daclatasvir in treatment of chronic hepatitis C genotype 4 infection in a cohort of egyptian patients: An experiment the size of egyptian village. Int J Hepatol  2018,2018,1-5","journal-title":"Int J Hepatol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.jacl.2017.04.115","volume":"11","author":"Abdeldyem S.M.","year":"2017","unstructured":"Abdeldyem S.M.; Goda T.; Khodeir S.A.; Abou Saif S.; Abd-Elsalam S.; Nonalcoholic fatty liver disease in patients with acute ischemic stroke is associated with more severe stroke and worse outcome. J Clin Lipidol  2017,11(4),915-919","journal-title":"J Clin Lipidol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2147\/DMSO.S237866","volume":"13","author":"Abo-Amer Y.E.E.","year":"2020","unstructured":"Abo-Amer Y.E.E.; Sabal A.; Ahmed R.; Relationship Between Helicobacter pylori infection and nonalcoholic fatty liver disease (NAFLD) in a developing country: A cross-sectional study. Diabetes Metab Syndr Obes  2020,13,619-25","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"102022","DOI":"10.1016\/j.eclinm.2023.102022","volume":"60","author":"Malekpour M.R.","year":"2023","unstructured":"Malekpour M.R.; Abbasi-Kangevari M.; Ghamari S.H.; The burden of metabolic risk factors in North Africa and the Middle East, 1990\u20132019: Findings from the Global Burden of Disease Study. Clin Med  2023,60,102022","journal-title":"Clin Med"}],"container-title":["Recent Advances in Anti-Infective Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127724344429679260220073151","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/251593\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0127724344429679260220073151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T06:44:06Z","timestamp":1792392246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/251593\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0127724344429679260220073151","relation":{},"ISSN":["2772-4344"],"issn-type":[{"value":"2772-4344","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-07-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-13","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-10-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}